Desmopressin: A nontransfusional hemostatic agent

Research output: Contribution to journalArticlepeer-review


Desmopressin (1-deamino-8-D-arginine vasopressin, DDAVP) is a synthetic analogue of the antidiuretic hormone L-arginine vasopressin. Because it can raise circulating levels of Factor VIII and of von Willebrand's factor, DDAVP is used for nontransfusional treatment of mild and moderate hemophilia and von Willebrand's disease. DDAVP also shortens the prolonged skin bleeding time in patients with uremia, liver cirrhosis, and platelet dysfunctions and is given to prevent or stop excessive bleeding in such conditions. Finally, there is evidence that DDVAP can reduce blood loss and transfusion requirements during and after surgical operations in which blood losses are unusually large. Hence DDAVP is useful as a nontransfusional hemostatic agent in many of the bleeding disorders frequently encountered in clinical practice.

Original languageEnglish
Pages (from-to)55-64
Number of pages10
JournalAnnual Review of Medicine
Publication statusPublished - 1990


  • cardiac surgery
  • hemophilia
  • liver cirrhosis
  • uremia
  • von Willebrand's disease

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Desmopressin: A nontransfusional hemostatic agent'. Together they form a unique fingerprint.

Cite this